(Q37874869)

English

Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases

scientific article published on 12 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

pharmacogenomics

1 reference

based on heuristic

inferred from title

decision making

1 reference

based on heuristic

inferred from title

Evelyne Jacqz-Aigrain

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Chiara Piana

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Linda Surh

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sabine Furst-Recktenwald

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Achille Iolascon

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ineke Jonker

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ron H N van Schaik

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Judith Wessels

9

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Oscar E Della Pasqua

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

12 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

704-716

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Developmental and pediatric pharmacogenomics

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Developmental pharmacology--drug disposition, action, and therapy in infants and children

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Clinical pharmacogenetics and potential application in personalized medicine

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

The genetic basis of variability in drug responses

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Multiple substrate binding by cytochrome P450 3A4: estimation of the number of bound substrate molecules.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Juvenile animal toxicity study designs to support pediatric drug development

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Pharmacogenetics of antiretrovirals

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Modelling and simulation as research tools in paediatric drug development

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

How children's responses to drugs differ from adults

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Systems-ADME/Tox: resources and network approaches

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Overview of pharmacogenetics in anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Developmental pharmacology: neonates are not just small adults...

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Statistical consideration for clinical biomarker research in bladder cancer

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Pharmacokinetics and metabolism of intravenous midazolam in preterm infants

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

The pharmacogenetics of methotrexate in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Ancestry and pharmacogenetics of antileukemic drug toxicity

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Dopamine transporter genotype influences the physiological response to medication in ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Isoniazid pharmacokinetics in children treated for respiratory tuberculosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Prolactin, the prolactin receptor and uncoupling protein abundance and function in adipose tissue during development in young sheep

1 reference

https://api.crossref.org/works/10.1177%2F0091270011401619

21 January 2018

Identifiers

10.1177/0091270011401619

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

release_ylduapjok5hllnztalt5mmhdvi

1 reference

https://api.fatcat.wiki/v0/release/ylduapjok5hllnztalt5mmhdvi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37874869&oldid=2120915471"